Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany F Chen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|February 21, 2013
Engineering fibronectin-based binding proteins by yeast surface displayTiffany F Chen, Seymour de Picciotto, Benjamin J Hackel, et al.
The Journal of Biological Chemistry|July 8, 2009
Role of dimerization in the catalytic properties of the Escherichia coli disulfide isomerase DsbCSilvia A Arredondo, Tiffany F Chen, Austen F Riggs, et al.
Chembiochem : a European Journal of Chemical Biology|February 13, 2013
Engineering new protein-protein interactions on the β-propeller fold by yeast cell surface displayKeya Zhang, Heng Li, Karan Bhuripanyo, et al.
Journal of Molecular Biology|June 19, 2012
Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repressionJamie B Spangler, Mandana T Manzari, Elizabeth K Rosalia, et al.
Journal of Molecular Biology|April 29, 2018
Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine FcγR TypesTiffany F Chen, Kevin K Li, Eric F Zhu, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2015
Protein Engineering and Selection Using Yeast Surface DisplayAlessandro Angelini, Tiffany F Chen, Seymour de Picciotto, et al.
Journal of Molecular Biology|July 12, 2017
Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAsTiffany F Chen, Stephen L Sazinsky, Damian Houde, et al.
Nature Communications|May 12, 2021
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeuticXuqing Zhang, Mengyao Luo, Shamael R Dastagir, et al.
JCI Insight|March 22, 2024
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetesGene I Uenishi, Marko Repic, Jennifer Y Yam, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|February 21, 2013
Engineering fibronectin-based binding proteins by yeast surface displayTiffany F Chen, Seymour de Picciotto, Benjamin J Hackel, et al.
The Journal of Biological Chemistry|July 8, 2009
Role of dimerization in the catalytic properties of the Escherichia coli disulfide isomerase DsbCSilvia A Arredondo, Tiffany F Chen, Austen F Riggs, et al.
Chembiochem : a European Journal of Chemical Biology|February 13, 2013
Engineering new protein-protein interactions on the β-propeller fold by yeast cell surface displayKeya Zhang, Heng Li, Karan Bhuripanyo, et al.
Journal of Molecular Biology|June 19, 2012
Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repressionJamie B Spangler, Mandana T Manzari, Elizabeth K Rosalia, et al.
Journal of Molecular Biology|April 29, 2018
Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine FcγR TypesTiffany F Chen, Kevin K Li, Eric F Zhu, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2015
Protein Engineering and Selection Using Yeast Surface DisplayAlessandro Angelini, Tiffany F Chen, Seymour de Picciotto, et al.
Journal of Molecular Biology|July 12, 2017
Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAsTiffany F Chen, Stephen L Sazinsky, Damian Houde, et al.
Nature Communications|May 12, 2021
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeuticXuqing Zhang, Mengyao Luo, Shamael R Dastagir, et al.
JCI Insight|March 22, 2024
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetesGene I Uenishi, Marko Repic, Jennifer Y Yam, et al.
Pageof 1